KASUMI-3/iRFP stable cell line

KASUMI-3/iRFP cells are derived from the human KASUMI-3 myeloblast cell line by stably integration of a constitutive miRFP670 stably expression construct. KASUMI-3 cell line was generated from acute myeloblastic leukemia (AML), has been widely used to study the mechanism of AML and evaluate the effects of new drugs or therapies. KASUMI-3/iRFP cells stably express miRFP670, can be used for in vitro assays and in vivo imaging.